Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
PLoS One. 2022 Dec 30;17(12):e0279552. doi: 10.1371/journal.pone.0279552. eCollection 2022.
Adrenal vein sampling (AVS) is the reference standard for evaluation of lateralized hormone production in primary aldosteronism. We aimed to investigate the impact of pre-interventional right renal vein (RRV) to right adrenal vein (RAV) distance measurement on fluoroscopy time, contrast agent exposure and radiation dose during AVS.
Forty-five patients with primary aldosteronism undergoing AVS were enrolled in our retrospective study and divided into three groups. In the group "ruler" (n = 14), RRV-RAV-distances were determined pre-interventionally by cross-sectional imaging (CT/MRI) and AVS was performed by one interventional radiologist with limited experience in AVS. CT/MRI-derived and fluoroscopy-derived RRV-RAV-distances were correlated for aimed cannulation of the RAV. Patients in group "no ruler" (n = 24, three interventional radiologists with limited experience in AVS) and in group "expert", (n = 7, one expert interventional radiologist) underwent AVS without pre-interventional estimation of RRV-RAV-distances. Procedure parameters (fluoroscopy time, contrast agent volume, radiation dose) of group "ruler" were compared to both other groups by Kruskal-Wallis rank-sum test.
Correlation of CT/MRI-derived and fluoroscopy-derived RRV-RAV-distances was good (r = 0.74;p = 0.003). The median RRV-RAV-distance was 4.5cm at CT/MRI (95%-CI:4.2-5.0cm) and 4.0cm at fluoroscopy (95%-CI:3.8-4.5cm). Fluoroscopy time (p<0.0001), contrast agent exposure (p = 0.0003) and radiation dose (air kerma and dose area product both p = 0.038) were significantly lower in group "ruler" compared to group "no ruler" (all p<0.05), and similar to group "expert" (all p>0.05).
CT/MRI-derived pre-interventional renal-adrenal vein distance measurements correlate well with angiographic distance measurements. Pre-interventional estimation of the RRV-RAV-distance allows for aimed cannulation of the RAV with potential reduction of fluoroscopy time, contrast agent exposure and radiation-dose during AVS.
肾上腺静脉取样 (AVS) 是评估原发性醛固酮增多症中激素侧化产生的参考标准。我们旨在研究在 AVS 前对右肾静脉 (RRV) 至右肾上腺静脉 (RAV) 距离的测量对透视时间、造影剂暴露和辐射剂量的影响。
我们对 45 例接受 AVS 的原发性醛固酮增多症患者进行了回顾性研究,并将其分为三组。在“标尺”组(n = 14)中,通过横断面成像(CT/MRI)在术前确定 RRV-RAV 距离,由一位 AVS 经验有限的介入放射科医生进行 AVS。CT/MRI 衍生和透视衍生的 RRV-RAV 距离与 RAV 的靶向插管相关。在无术前 RRV-RAV 距离估计的“无标尺”组(n = 24,三位 AVS 经验有限的介入放射科医生)和“专家”组(n = 7,一位专家介入放射科医生)中进行 AVS。通过 Kruskal-Wallis 秩和检验比较“标尺”组与其他两组的程序参数(透视时间、造影剂体积、辐射剂量)。
CT/MRI 衍生和透视衍生的 RRV-RAV 距离相关性良好(r = 0.74;p = 0.003)。RRV-RAV 距离在 CT/MRI 上的中位数为 4.5cm(95%CI:4.2-5.0cm),在透视下为 4.0cm(95%CI:3.8-4.5cm)。透视时间(p<0.0001)、造影剂暴露(p = 0.0003)和辐射剂量(空气比释动能和剂量面积产物均为 p = 0.038)在“标尺”组明显低于“无标尺”组(均为 p<0.05),与“专家”组相似(均为 p>0.05)。
CT/MRI 术前衍生的肾-肾上腺静脉距离测量与血管造影距离测量相关性良好。在 AVS 前对 RRV-RAV 距离的估计可以实现 RAV 的靶向插管,潜在地减少 AVS 中的透视时间、造影剂暴露和辐射剂量。